{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:39:31Z","timestamp":1779136771404,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008234","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["DEC2016\/21\/B\/ST7\/02241"],"award-info":[{"award-number":["DEC2016\/21\/B\/ST7\/02241"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1008234","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T17:57:12Z","timestamp":1601920632000},"page":"e1008234","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3069-3085","authenticated-orcid":true,"given":"Emilia","family":"Koz\u0142owska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3895-7938","authenticated-orcid":true,"given":"Rafa\u0142","family":"Suwi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Giglok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"\u015awierniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8161-890X","authenticated-orcid":true,"given":"Marek","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"key":"pcbi.1008234.ref001","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: An evolving paradigm","volume":"13","author":"C Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"pcbi.1008234.ref002","first-page":"575","article-title":"A view on drug resistance in cancer","author":"N Vasan","year":"2019","journal-title":"Nature"},{"key":"pcbi.1008234.ref003","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2010.33.2312","article-title":"Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling","volume":"29","author":"N Wagle","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"pcbi.1008234.ref004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2017.01.003","article-title":"Tumor evolution: Linear, branching, neutral or punctuated?","volume":"1867","author":"A Davis","year":"2017","journal-title":"Biochim. Biophys. Acta\u2014Rev. Cancer"},{"key":"pcbi.1008234.ref005","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1534\/genetics.105.049791","article-title":"Evolution of resistance during clonal expansion","volume":"172","author":"Y Iwasa","year":"2006","journal-title":"Genetics"},{"key":"pcbi.1008234.ref006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"PS Hammerman","year":"2012","journal-title":"Nature"},{"key":"pcbi.1008234.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007669","article-title":"Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability","volume":"14","author":"F Raynaud","year":"2018","journal-title":"PLoS Genet"},{"key":"pcbi.1008234.ref008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network","volume":"511","author":"EA Collisson","year":"2014","journal-title":"Nature"},{"key":"pcbi.1008234.ref009","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review","volume":"322","author":"KC Arbour","year":"2019","journal-title":"JAMA\u2014J. Am. Med. Assoc"},{"key":"pcbi.1008234.ref010","first-page":"2164","article-title":"Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors In Brief","volume":"29","author":"A Sharma","year":"2019","journal-title":"CellReports"},{"key":"pcbi.1008234.ref011","doi-asserted-by":"crossref","first-page":"e1005093","DOI":"10.1371\/journal.pcbi.1005093","article-title":"In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model","volume":"12","author":"E Kolokotroni","year":"2016","journal-title":"PLOS Comput. Biol"},{"key":"pcbi.1008234.ref012","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-28095-0","article-title":"System engineering approach to planning anticancer therapies","author":"A \u015awierniak","year":"2016","journal-title":"System Engineering Approach to Planning Anticancer Therapies (Springer International Publishing"},{"key":"pcbi.1008234.ref013","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2009.08.041","article-title":"Mathematical modeling as a tool for planning anticancer therapy","volume":"625","author":"A Swierniak","year":"2009","journal-title":"European Journal of Pharmacology vol"},{"key":"pcbi.1008234.ref014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11864-015-0338-4","volume":"16","author":"N Katsumata","year":"2015","journal-title":"Dose-Dense Approaches to Ovarian Cancer Treatment. Curr. Treat. Options Oncol"},{"key":"pcbi.1008234.ref015","first-page":"2019","article-title":"Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience","author":"C Simsek","year":"2019","journal-title":"Journal of Oncology vol"},{"key":"pcbi.1008234.ref016","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy","volume":"69","author":"RA Gatenby","year":"2009","journal-title":"Cancer Res"},{"key":"pcbi.1008234.ref017","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1038\/s41598-017-13646-z","article-title":"Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model","volume":"7","author":"C Geng","year":"2017","journal-title":"Sci. Rep"},{"key":"pcbi.1008234.ref018","doi-asserted-by":"crossref","unstructured":"Bajger P, Fujarewicz K, Swierniak A. Effects of Pharmacokinetics and DNA Repair on the Structure of Optimal Controls in a Simple Model of Radio-Chemotherapy. in 2018 23rd International Conference on Methods and Models in Automation and Robotics, MMAR 2018 686\u2013691 (Institute of Electrical and Electronics Engineers Inc., 2018). doi: 10.1109\/MMAR.2018.8485901","DOI":"10.1109\/MMAR.2018.8485901"},{"key":"pcbi.1008234.ref019","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/CCI.19.00133","article-title":"Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer","author":"C Nicol\u00f2","year":"2020","journal-title":"JCO Clin. Cancer Informatics"},{"key":"pcbi.1008234.ref020","first-page":"263335","article-title":"Competitive release in tumors","author":"Y Ma","year":"2018","journal-title":"bioRxiv"},{"key":"pcbi.1008234.ref021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/annonc\/mdf013","article-title":"Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels","volume":"13","author":"M Colleoni","year":"2002","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol"},{"key":"pcbi.1008234.ref022","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2004.08.006","article-title":"Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC).","volume":"58","author":"A Nicolini","year":"2004","journal-title":"Biomed. Pharmacother"},{"key":"pcbi.1008234.ref023","first-page":"133","article-title":"A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients","volume":"16","author":"P Correale","year":"2006","journal-title":"Oncol. Rep"},{"key":"pcbi.1008234.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"M. Yuan","year":"2019","journal-title":"Signal Transduct. Target. Ther"},{"key":"pcbi.1008234.ref025","doi-asserted-by":"crossref","unstructured":"Sch\u00e4ttler H, Ledzewicz U. Optimal Control for Mathematical Models of Cancer Therapies: An Application of Geometric Methods. Optimal Control for Mathematical Models of Cancer Therapies: An Application of Geometric Methods vol. 42 (Springer Science and Business Media, LLC, 2015).","DOI":"10.1007\/978-1-4939-2972-6"},{"key":"pcbi.1008234.ref026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"CG Zubrod","year":"1960","journal-title":"J. Chronic Dis"},{"key":"pcbi.1008234.ref027","first-page":"1618","article-title":"The IASLC Lung Cancer Staging Project","volume":"9","author":"R Rami-Porta","year":"2014","journal-title":"The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer. J. Thorac. Oncol"},{"key":"pcbi.1008234.ref028","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jcmm.12408","article-title":"The role of the cell-cell interactions in cancer progression","volume":"19","author":"K Kami\u0144ska","year":"2015","journal-title":"J. Cell. Mol. Med"},{"key":"pcbi.1008234.ref029","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc3971","article-title":"Tumorigenesis: It takes a village","volume":"15","author":"DP Tabassum","year":"2015","journal-title":"Nature Reviews Cancer vol"},{"key":"pcbi.1008234.ref030","first-page":"6212","article-title":"An evolutionary model of carcinogenesis","volume":"63","author":"RA Gatenby","year":"2003","journal-title":"Cancer Res"},{"key":"pcbi.1008234.ref031","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"RJ Gillies","year":"2012","journal-title":"Nature Reviews Cancer vol"},{"key":"pcbi.1008234.ref032","first-page":"102","article-title":"The fate of competing beneficial mutations in an asexual population","volume":"103","author":"PJ Gerrish","year":"1998","journal-title":"Genetica"},{"key":"pcbi.1008234.ref033","first-page":"163","article-title":"The Norton-Simon hypothesis revisited","volume":"70","author":"L Norton","year":"1986","journal-title":"Cancer Treat. Rep"},{"key":"pcbi.1008234.ref034","first-page":"1307","article-title":"Tumor size, sensitivity to therapy, and design of treatment schedules","volume":"61","author":"L Norton","year":"1977","journal-title":"Cancer Treat. Rep"},{"key":"pcbi.1008234.ref035","first-page":"27","article-title":"Nonlinear Elimination of Drugs in One-Compartment Pharmacokinetic Models: Nonstandard Finite Difference Approach for Various Routes of Administration","volume":"23","author":"O Egbelowo","year":"2018","journal-title":"Math. Comput. Appl"},{"key":"pcbi.1008234.ref036","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/JTO.0b013e31817c9230","article-title":"Turning gray: The natural history of lung cancer over time","volume":"3","author":"FC Detterbeck","year":"2008","journal-title":"J. Thorac. Oncol"},{"key":"pcbi.1008234.ref037","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejca.2016.07.024","article-title":"Phase i trials in melanoma: A framework to translate preclinical findings to the clinic","volume":"67","author":"E Kim","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"pcbi.1008234.ref038","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-17-3746","article-title":"Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer","volume":"78","author":"E Koz\u0142owska","year":"2018","journal-title":"Cancer Res"},{"key":"pcbi.1008234.ref039","first-page":"17","article-title":"A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice","author":"WJ Aston","year":"2017","journal-title":"BMC Cancer"},{"key":"pcbi.1008234.ref040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3892\/or.2013.2279","article-title":"Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation","volume":"29","author":"L Astolfi","year":"2013","journal-title":"Oncol. Rep"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008234","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T19:02:51Z","timestamp":1602788571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008234"}},"subtitle":[],"editor":[{"given":"Attila","family":"Csik\u00e1sz-Nagy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008234","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1008234","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]}}}